Circulating tumor cells in early bladder cancer: Insight into micrometastatic disease

Expert Review of Molecular Diagnostics

Volumn 14, Issue 4, 2014, Pages 407-409

  Raimondi, Cristina ^a   Gradilone, Angela ^a   Gazzaniga, Paola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

circulating tumor cells; early bladder cancer; micrometastatic disease; prognosis

Indexed keywords

ADJUVANT CHEMOTHERAPY; BLADDER CANCER; BREAST CANCER; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CIRCULATING TUMOR CELL; CYSTECTOMY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EARLY CANCER; HUMAN; METASTASIS; MICROMETASTASIS; NON MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; REVIEW; EARLY DIAGNOSIS; PATHOLOGY; PERSONALIZED MEDICINE; TUMOR EMBOLISM; URINARY BLADDER NEOPLASMS;

EARLY DETECTION OF CANCER; HUMANS; INDIVIDUALIZED MEDICINE; NEOPLASM MICROMETASTASIS; NEOPLASTIC CELLS, CIRCULATING; URINARY BLADDER NEOPLASMS;

EID: 84898978284     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.2014.908119     Document Type: Review

References (16)

1. van den Bosch S, Alfred Witjes J. Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review. Eur Urol 2011;60: 493-500
2. Edge SB, Byrd DR, Compton CC, et al. editors. AJCC cancer staging manual. 7th edition Springer, New York, NY; 2010. p. 347-76
3. Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 2013;23(5):573-81
4. Knowles MA. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis 2006;27(3): 361-73 (Pubitemid 43372866
5. Sylvester RJ. How well can you actually predict which non-muscle-invasive bladder cancer patients will progress? Eur Urol 2011;60:431-4
6. Gazzaniga P, Raimondi C, Gradilone A, et al. Circulating tumor cells: highlight on practical implications. Mol Diagn Ther 2012;16:7-11
7. Tomasini JM, Konety BR. Urinary markers/cytology: what and when should a urologist use. Urol Clin North Am 2013;40(2): 165-73
8. Flaig TW, Wilson S, van Bokhoven A, et al. Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma. Urology 2011;78:863-7
9. Rink M, Chun FK, Minner S, et al. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer. BJU Int 2011;107:1668-75
10. Gallagher DJ, Milowsky MI, Ishill N, et al. Detection of circulating tumor cells in patients with urothelial cancer. Ann Oncol 2009;20:305-8
11. Rink M, Chun FK, Dahlem R, et al. Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study. Eur Urol 2012;61(4): 810-17
12. Gradilone A, Petracca A, Nicolazzo C, et al. Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer. BJU Int 2010;106(5):710-15
13. Gazzaniga P, Gradilone A, de Berardinis E, et al. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. Ann Oncol 2012; 23(9):2352-6
14. Gazzaniga P, de Berardinis E, Raimondi C, et al. Circulating tumor cells detection has independent prognostic impact in high risk non muscle invasive bladder cancer. Int J Cancer 2014. [Epub ahead of print]
15. Leow JJ, Martin-Doyle W, Padma S. Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials. Eur Urol 2013. [Epub ahead of print]
16. Gore JL, Gilbert SM. Improving bladder cancer patient care: a pharmacoeconomic perspective. Expert Rev Anticancer Ther 2013;13(6):661-8